The first-ever treatment for malaria in young babies and infants has been approved. On Tuesday, Novartis announced it had received approval for the treatment, Coartem Baby (known as Riamet Baby in ...

The medicine, called Coartem Baby (also known as Riamet Baby), was approved by Switzerland’s health agency, Swissmedic. HealthDay News — A new malaria treatment has been approved for newborns and ...

Add Yahoo as a preferred source to see more of our stories on Google. Spread largely by mosquitos, Malaria causes a fever, headaches, confusion and muscle pains among other symptoms and can be fatal.

Add Yahoo as a preferred source to see more of our stories on Google. GanLum achieved a 97.4% PCR-corrected cure rate compared to 94% with standard of care Novartis’ anti-malaria drug could mark the ...

The study reveals that ARK1 controls spindle formation during malaria parasite division. Blocking this protein disrupted ...

NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Complete list of 2026 ...

New research shows the malaria parasite could be developing resistance to the current front-line treatment for the disease — a drug that has saved millions of lives. An anti-malaria drug that has ...

The world’s largest malaria conference closed in Nairobi on Friday amid calls for substantial and sustained support for research to save countless lives. While the conference showcased new ...

Researchers analyzed the genomes of hundreds of malaria parasites to determine which genetic variants are most likely to confer drug resistance. Researchers at University of California San Diego ...

WASHINGTON (WUSA9) — For decades, the Department of Defense ordered tens of thousands of American service members to take a drug intended to prevent malaria, a mosquito-borne disease that can kill.